Skip to main content
. Author manuscript; available in PMC: 2019 Jul 21.
Published in final edited form as: Sci Signal. 2018 Feb 20;11(518):eaao0422. doi: 10.1126/scisignal.aao0422

Fig. 5. Abl and Arg induce NF-kB (p65/RelA), Ets1 and Sp1.

Fig. 5.

Cells transfected with siRNAs (A,B) or treated with nilotinib (C,D) were lysed and blotted (A,C), or fractionated into nuclear and cytoplasmic fractions and blotted (B,D). pCrkL blots demonstrate efficiency of Abl/Arg inhibition by nilotinib. (E) TCGA data was downloaded and correlations assessed as described in Fig. 4.